跳转至内容
Merck
CN

SML2720

Miriplatin

>97.5% (Pt analysis)

别名:

Cyclohexane-(1R,2R)-diamineplatinum(II) dimyristate, MPT, SM-11355

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C34H68N2O4Pt
化学文摘社编号:
分子量:
763.99
UNSPSC Code:
12352200
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/2C14H28O2.C6H12N2.Pt/c2*1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16;7-5-3-1-2-4-6(5)8;/h2*2-13H2,1H3,(H,15,16);5-8H,1-4H2;/q;;-2;+4/p-2/t;;5-,6-;/m..1./s1

InChI key

DTRJSYSQELJDAW-BLUNCNMSSA-L

SMILES string

CCCCCCCCCCCCCC(O[Pt]1(N[C@@H]2CCCC[C@H]2N1)OC(CCCCCCCCCCCCC)=O)=O

assay

>97.5% (Pt analysis)

form

powder

storage condition

desiccated

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

−20°C

Quality Level

Biochem/physiol Actions

Miriplatin (SM-11355) is a platinum (II) complex-based anti-neoplastic agent with increased lipophilicity than its family members cisplatin and carboplatin.
Platinum (II) complex-based anti-neoplastic agent with increased lipophilicity than cisplatin and carboplatin.

存储类别

11 - Combustible Solids

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Kenji Ikeda et al.
Hepatology research : the official journal of the Japan Society of Hepatology, 47(7), 632-640 (2016-08-04)
The effect of transcatheter arterial chemoembolization (TACE) is not necessarily sufficient in patients with multiple hepatocellular carcinoma (HCC). We evaluated the antitumor activity and adverse events of TACE using warmed miriplatin suspension for multiple HCC. Seventy patients with multiple HCC
Toru Ishikawa et al.
Molecular and clinical oncology, 5(5), 511-516 (2016-11-25)
Transcatheter arterial chemoembolization (TACE) is the standard therapy for Barcelona Clinic Liver Cancer (BCLC) classification intermediate stage B hepatocellular carcinoma (HCC). However, other transcatheter methods, such as transcatheter arterial infusion (TAI), also play an important role in the treatment of
Shan Liu et al.
Journal of pharmaceutical sciences, 105(1), 78-87 (2016-02-09)
Because of the insolubility of miriplatin in water, miriplatin and lipiodol suspension is the sole formulation of miriplatin approved in Japan to treat hepatocellular carcinoma by transcatheter arterial chemoembolization. Until now, there have been no reports of other pharmaceutical formulations

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持